This article summarizes a report from 2016 about the incredible spending by Big Pharma to promote opioids during the period when opioid abuse was rising. The original report, written by the AP is available at Drugmakers fought state opioid limits amid crisis.
It has relevance today because 50-state lobbying strategies costing $880 million over a nine year period do not simply fold up tend and go away. Big Pharma has been remarkably consistent in its use of tactics, non-profit front groups, direct marketing to doctors and political contributions to sell more drugs. These approaches directly relate to today’s debate about Medication-Assisted Treatment (MAT), the prescription and distribution of addictive drugs to those who were victimized by the last round of drug company marketing of opioids.